Article

San Jose Mercury NewsSan Jose Mercury News on 2024-05-25 08:05

High price of popular diabetes drugs deprives low-income people of effective treatment

About 54% of adults who had taken a GLP-1 drug, including those with insurance, said the cost was “difficult” to afford, according to a poll.

Related news